AHA, AARP CEOs Highlight ‘Exorbitantly-priced Drugs’ in Hill OpEd
AHA President and CEO Rick Pollack and AARP CEO Jo Ann Jenkins today authored an OpEd in The Hill discussing the skyrocketing costs of prescription drugs and what they mean for patients and our health care system. “Ultimately, the current system of exorbitantly-priced drugs is unsustainable for everyone — patients, employers, insurers, and taxpayer-funded programs like Medicare and Medicaid,” they wrote. “We stand ready to work together to find commonsense and innovative solutions that will help make drugs affordable for everyone.” Read more.
Related News Articles
Headline
The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes…
Headline
The Department of Health and Human Services and Drug Enforcement Administration Dec. 30 released a temporary rule extending for the fourth time waiver…
Headline
The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model for Medicare Part D and Medicaid beneficiaries. The Better…
Headline
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. The first proposed…
Headline
The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid…
Headline
The AHA has released its 2026 Environmental Scan, a comprehensive resource designed to help hospitals and health systems navigate a rapidly evolving landscape…